Inovio Pharmaceuticals Inc


Market Cap$2.09B

Compare Inovio Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Inovio Pharmaceuticals IncInovio Pharmaceuticals Inc-12.70%-119%-0.1
marketMarket Avg49.61.28%30%6.11.1
IndustrialsIndustrials Avg19.10.99%21%3.10.6

Current Fair Value

0.7% upside

Undervalued by 0.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.09 Billion
Enterprise Value$1.94 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.63
Outstanding Shares272,986,424
Avg 30 Day Volume469,309


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-12.71
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue2271.7
Enterprise Value to EBIT-11.88
Enterprise Value to Net Income-12
Total Debt to Enterprise0.01
Debt to Equity0.12

Revenue Sources

No data

ESG Score

No data

About Inovio Pharmaceuticals Inc

CEO: Jong Kim